Literature DB >> 1805720

Pharmacokinetics of total and free digoxin and Fab fragments in 5 intoxicated patients after administration of specific anti-digoxin Fab fragments.

M Urtizberea1, A Sabouraud, M Lachaise, O Chappey, V Cosson, F J Baud, J M Scherrmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1805720     DOI： 10.1007/978-3-642-74936-0_26

Source DB:  PubMed          Journal:  Arch Toxicol Suppl        ISSN： 0171-9750


× No keyword cloud information.
  3 in total

1.  Development of a sensitive radioimmunoassay for Fab fragments: application to Fab pharmacokinetics in humans.

Authors:  C V Thanh-Barthet; M Urtizberea; A E Sabouraud; N J Cano; J M Scherrmann
Journal:  Pharm Res       Date:  1993-05       Impact factor: 4.200

Review 2.  Pharmacokinetic aspects of digoxin-specific Fab therapy in the management of digitalis toxicity.

Authors:  M R Ujhelyi; S Robert
Journal:  Clin Pharmacokinet       Date:  1995-06       Impact factor: 6.447

3.  Anti-colchicine Fab fragments prevent lethal colchicine toxicity in a porcine model: a pharmacokinetic and clinical study.

Authors:  Michael Eddleston; Nicolas Fabresse; Adrian Thompson; Ibrahim Al Abdulla; Rachael Gregson; Tim King; Alain Astier; Frederic J Baud; R Eddie Clutton; Jean-Claude Alvarez
Journal:  Clin Toxicol (Phila)       Date:  2018-01-15       Impact factor: 4.467
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.